Short answer
COA documentation is the batch-specific record of what was tested on a peptide lot, by which method, against which limit, and with what result. LPS testing (also called endotoxin testing) appears on a peptide COA only when it was actually performed: look for a bacterial endotoxins line with the method, result, units, and acceptance limit. Quantitative assays can report an EU value; a suitable gel-clot limit test can report pass/fail against a stated threshold. If no endotoxin line appears, endotoxin was not documented for that lot.
For a guide to every section of a certificate of analysis, see certificates of analysis: what researchers need to know.
What Is COA Documentation?
This documentation is the set of records that links a specific peptide lot to dated analytical results: the certificate of analysis itself, plus the methods, limits, and lab details behind each result. Good Manufacturing Practice (GMP) guidance sets the benchmark: a certificate should list each test performed, its acceptance limits, and the numerical results obtained, and be dated and signed by authorized quality staff.1
That guidance applies to pharmaceutical manufacturing, not to research materials.1 For research peptides, a COA is evidence rather than a guarantee, and its value depends on how complete and traceable it is.
Is a COA Required for Research Peptides?
For research materials, there is generally no single universal legal requirement for a COA; institutional policies, quality systems, and good practice usually drive it. Funders can add expectations: NIH, for example, expects applicants to authenticate key chemical resources.2
What Information Is Typically Included in Peptide COA Documentation
A peptide COA typically reports the product name and lot number, an identity result, a purity result, and any contaminant tests that were run, each with its method, limit, and result, followed by the test date and an approval signature or code.1 Endotoxin is one of those optional contaminant tests; for the full field list, see what a good peptide COA should include: 12 non-negotiables.
What Is LPS and Why It Appears in COA Discussions
Endotoxin is lipopolysaccharide (LPS) from the outer membrane of Gram-negative bacteria. FDA uses LPS as a name synonymous with bacterial endotoxins and measures endotoxin activity in endotoxin units (EU).3 On a COA, “LPS” and “bacterial endotoxins” refer to the same test.
LPS appears in COA discussions because it is hard to see and hard to remove. It is highly heat stable,4 and regular sterilizing conditions such as autoclaving do not destroy it.5 It also matters at trace levels: in one study, primary dendritic cells responded to LPS concentrations as low as 0.02 ng/mL, and the authors warned that even low endotoxin contamination may generate erroneous data in LPS-sensitive cells.6
How LPS Testing Fits Into Peptide COA Documentation
When LPS testing is performed, it appears as one line on the COA: the test name, the method, the limit, the result with its basis (per mg, per mL, or per vial), and a pass or conforms statement. If no endotoxin line appears, endotoxin was not documented for that lot.
Endotoxin testing is often a separate option rather than a default. GenScript, for example, offers an endotoxin control service with a specified level of <0.01 EU/µg, and an analysis-only service that reports the result without a set level.7

Annotated Sample COA: Endotoxin Fields
The table shows the LPS-related fields on a typical peptide COA. Example entries are illustrative only; they are not recommended limits.
| COA field | Illustrative entry | What to check |
|---|---|---|
| Lot number and test date | Lot 0000-A, tested on a stated date | Matches your vial; the result is a point-in-time measurement |
| Test name | Bacterial endotoxins (LPS) | Present at all; no line means not documented |
| Method | Kinetic chromogenic LAL (color change read over time), or recombinant Factor C | A named method, ideally with its pharmacopeial chapter8, 9 |
| Limit | For example, ≤1 EU/mg | A stated limit, not “Pass” alone1 |
| Result | For example, <0.5 EU/mg | A quantitative value or valid limit-test result, with units and threshold; “<” does not mean zero10 |
| Basis | EU per mg, per mL, or per vial | Matches the way you will calculate your working concentration |
| Assay validity | Spike recovery within range | Shows the sample did not suppress the signal10 |
| Lab and approval | Lab name, report number, signature | Traceable to a lab you can contact1 |
Common LPS Testing Methods Referenced in COAs
Most COAs that report endotoxin cite a Limulus amebocyte lysate (LAL) bacterial endotoxins test in one of three formats: gel-clot, turbidimetric, or chromogenic.10 Some cite recombinant Factor C (rFC) reagents, which USP covers in a separate chapter, <86>.9
The format matters when you read the number. Gel-clot tests give a qualitative positive or negative answer, while turbidimetric and chromogenic methods can give quantitative results.4 LAL detects only endotoxins.11 A side-by-side comparison is in comparing LPS detection methods: LAL, rFC, and MAT.

Interpreting LPS Results on a COA
Read an endotoxin result with its method, basis (per mg, per mL, or per vial), and acceptance limit. Quantitative results give an EU value or reporting bound; a valid gel-clot limit test can give pass/fail against a stated threshold. A result written with a less-than sign, such as “<0.5 EU/mg”, means no endotoxin was found above the assay’s lowest reportable level after correcting for dilution; the harmonized pharmacopeial test reports such results as “less than” the assay sensitivity.10 It does not mean zero.
Next, translate the result into your own conditions. Illustrative arithmetic: a peptide at 1 EU/mg, made into a 1 mg/mL stock and used at 10 µg/mL in a culture well, adds about 0.01 EU/mL to that well. For context, recombinant protein suppliers commonly specify less than 1 EU per µg, roughly 100 pg of LPS, and the same study found that this level can be enough to activate sensitive cells.6 Pharmaceutical endotoxin limits are calculated for each product,12 so they are not a benchmark for a cell assay. More on EU figures is in LPS detection sensitivity and EU/mL specifications.
A low result is only as reliable as the assay behind it. Storage and handling can affect whether endotoxin is detected,12 and some sample matrices suppress the signal; see endotoxin masking and interference in peptide samples.
Glossary of Common COA Terms and Abbreviations
- EU (endotoxin unit): the measure of endotoxin activity.3
- LAL / rFC: lysate-based and recombinant reagents used to test for endotoxin.8, 9
- λ (lambda): the labeled lysate sensitivity in gel-clot tests, or the lowest standard in photometric tests.10
- MVD (maximum valid dilution): the greatest dilution at which the endotoxin limit can still be determined;10 diluting further makes a negative result meaningless.3
- PPC (positive product control): the sample spiked with known endotoxin; recovery of 50% to 200% (photometric methods, per USP <85>) shows the sample did not interfere.8, 10
What COA Documentation Does Not Tell You
A COA cannot tell you about endotoxin introduced after testing, about tests it does not list, or whether its result is low enough for your experiment.
- Whether endotoxin entered during shipping, storage, or reconstitution
- Anything about tests that are not listed, such as microbial counts or other pyrogens
- Whether the method was checked for interference with this particular peptide
- Whether a passing result is low enough for an LPS-sensitive cell model
- How other lots of the same product performed
Why COA Documentation Should Be Viewed as One Data Point
View a COA as one data point because even regulated manufacturers do not accept a supplier’s certificate on sight. Under ICH Q7, the international GMP guideline for active pharmaceutical ingredients, a supplier’s COA can replace other testing only when suppliers are evaluated, at least one identity test is still run, and the reliability of certificates is checked at regular intervals.1
Independent checks show why. In one published evaluation, 43 of 98 peptides (44%) met their stated purity of at least 95% when the researchers ran their own quality control.13 For endotoxin, the dendritic cell study found one recombinant protein at 1.4 EU/µg against a stated level below 1 EU/µg, and several others slightly above their datasheet values.6
Best Practices for Reviewing COA Documentation as a Researcher
Review the certificate in a fixed order, and decide before the lot goes into an experiment whether the endotoxin record is enough for that experiment.
- 1Match the lot Confirm that the lot number on the COA matches the vial.
- 2Find the endotoxin line No line means no documented endotoxin result.
- 3Check method and limit Note the named method and the stated limit.
- 4Read the result and basis Convert the quantitative result or reported upper bound to your working concentration.
- 5Check validity and source Look for spike recovery, a lab name, a report number, and a date.
- 6File and decide Keep the COA with your lot records so the material can be authenticated,2 and test in-house if your model is LPS-sensitive.
Transparency and Traceability in Modern Peptide COAs
A transparent COA reports results in a form appropriate to the method, names the acceptance limit and testing lab, and can be traced from the vial’s lot number to a dated report. A valid limit test may report pass/fail; the threshold and units make that result interpretable. GMP guidance also expects certificates to name the original manufacturer, so a reissued COA should refer back to the original.1
Where a report shows only pass/fail, ask for the method, units, and acceptance limit for your lot. Ask for a numerical value if a quantitative assay was performed; a qualitative limit test may not produce one.
Common Misconceptions About COA Documentation
Most misconceptions come from reading more into a COA than it states.
| Misconception | What is actually true |
|---|---|
| High purity means low endotoxin | Purity and endotoxin are separate tests; one cannot stand in for the other |
| “<0.5 EU/mg” means endotoxin free | It means below the assay’s reportable level10 |
| No endotoxin line means it passed | It means endotoxin was not documented for that lot |
| A pass suits any experiment | Pharmaceutical limits are product specific, and sensitive cells respond to trace LPS6, 12 |
Using COA Documentation to Support Better Research Decisions
Use the COA to decide how much extra checking a lot needs, matched to how LPS-sensitive the experiment is. For immune cell, inflammation, or primary culture work, confirm that the reported value or limit is low enough for your model, and obtain additional testing if it is not informative enough; for LPS-insensitive analytical work, a complete identity and purity record may be enough.
After the vial is opened, endotoxin control becomes the lab’s job; see designing LPS-free protocols for peptide reconstitution.
Frequently Asked Questions About LPS Testing on COAs
What is COA documentation?
It is the batch-specific record of the tests run on a peptide lot, with each method, acceptance limit, quantitative or valid limit-test result, test date, and the issuing lab.1
Does a peptide COA include endotoxin testing?
Only if endotoxin testing was performed for that lot. It is often a separate option,7 so look for a bacterial endotoxins line with a method and an EU result.
What does LPS mean on a COA?
LPS stands for lipopolysaccharide, the bacterial endotoxin from Gram-negative bacteria; an LPS line reports endotoxin activity in EU.3
How should researchers interpret COA data?
Match the lot number, check identity and purity against their limits, then read any endotoxin result with its basis, method, and acceptance limit. Convert the value or upper bound to your working concentration.
Is COA documentation required for research peptides?
For research materials, there is generally no single universal legal requirement for a COA; institutional policies, quality systems, and good practice usually drive it.
Where does COA testing occur in the peptide lifecycle?
Usually after synthesis, purification, and lyophilization, on the finished lot before it ships. Anything that happens to the material afterward is outside the COA.
All peptides discussed here are for research use only.
Key Takeaways
- A COA records what was tested on one lot, by which method, against which limit, with what result.
- LPS testing appears on a COA only if it was performed; no endotoxin line means no documented result.
- Read the endotoxin result with its method, units, and acceptance limit. A valid limit test can report pass/fail; “<” does not mean zero.
- Convert the quantitative result or upper bound to your working concentration and compare it with how LPS-sensitive your model is.
- Read the COA as one data point: it describes the lot when tested, not after shipping or reconstitution.
References
- US Food and Drug Administration / International Council for Harmonisation. Q7 Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients. Guidance for industry (section 1.3 scope, section 7.3 testing of incoming materials, and section 11.4 certificates of analysis). fda.gov
- National Institutes of Health. Guidance: Rigor and Reproducibility in Grant Applications (authentication of key biological and/or chemical resources). grants.nih.gov
- US Food and Drug Administration. Bacterial Endotoxins/Pyrogens. Inspection technical guide. fda.gov
- D’Amico D. Endotoxins 101: Guide to Bacterial Endotoxin/LAL Testing. Thermo Fisher Scientific, Life in the Lab, September 2024. thermofisher.com
- Magalhães PO, Lopes AM, Mazzola PG, Rangel-Yagui C, Penna TCV, Pessoa A Jr. Methods of endotoxin removal from biological preparations: a review. Journal of Pharmacy and Pharmaceutical Sciences. 2007;10(3):388-404. J Pharm Pharm Sci
- Schwarz H, Schmittner M, Duschl A, Horejs-Hoeck J. Residual endotoxin contaminations in recombinant proteins are sufficient to activate human CD1c+ dendritic cells. PLoS One. 2014;9(12):e113840. PMC4257590
- GenScript. Peptide Endotoxin Control and Analysis (service description). genscript.com
- United States Pharmacopeia. General Chapter <85> Bacterial Endotoxins Test. USP-NF. uspnf.com
- United States Pharmacopeia. Notice: General Chapter <86> Bacterial Endotoxins Test Using Recombinant Reagents (official May 2025). July 2024. usp.org
- Pharmacopoeial Discussion Group. Bacterial Endotoxins Test (BET), Revision 2 (harmonized text for the European, Japanese, and United States pharmacopoeias; sign-off cover sheet, version 2). pmda.go.jp
- MilliporeSigma (Merck). Pyrogen Testing (monocyte activation test, Ph. Eur. 2.6.30). sigmaaldrich.com
- US Food and Drug Administration. Pyrogen and Endotoxins Testing: Questions and Answers (Edition 2). Guidance for industry, March 2026. fda.gov
- Verbeke F, Wynendaele E, Braet S, D’Hondt M, De Spiegeleer B. Quality evaluation of synthetic quorum sensing peptides used in R&D. Journal of Pharmaceutical Analysis. 2015;5(3):169-181. PMC5762210

